Back to 
BlackRock, Inc.
BlackRock, Inc.
HALO7 quarters
Position history for BlackRock, Inc.'s holdings in HALOZYME THERAPEUTICS INC
BlackRock, Inc. holds 13.3M shares of HALO (HALOZYME THERAPEUTICS INC), worth $1B as of 2026-Q2. The position was increased (+0.1% shares). HALO represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$1B
Current Shares
13.3M
Total Value Change
+$198.9M
Total Shares Change
-4.3M
Quarter-by-Quarter History
Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., VANGUARD GROUP INC